Limited Competition for Clinical Trials in Type 1 Diabetes (UC4) | Apply Online

Opportunity Summary:

The Limited Competition for Clinical Trials in Type 1 Diabetes (UC4) funding opportunity (RFA-DK-12-511) is a National Institutes of Health (NIH) announcement designed to move a specific set of previously planned Type 1 diabetes clinical trials into the full implementation stage. It is a limited competition, meaning not everyone can apply; only applicants who already received an R34 clinical trial planning grant funded under RFA-DK-11-010 are eligible. In practical terms, the UC4 mechanism is being used to fund the actual conduct of the clinical trials that were proposed and developed during the earlier R34 planning phase, rather than supporting brand-new trial ideas from the broader research community.

The scientific purpose of the program is focused on clinical trials in Type 1 diabetes that aim to improve glycemic control and/or to treat, prevent, or reduce diabetes-related complications. The emphasis on glycemic control and complications signals that the trials are expected to have clear clinical relevance, likely involving interventions, strategies, or approaches intended to improve outcomes for people living with Type 1 diabetes. Because this FOA is tied directly to the R34 planning awards, it is essentially a follow-on opportunity that supports translation from trial design and feasibility work into real-world trial execution.

From an administrative and funding standpoint, the award uses a Cooperative Agreement (UC4) funding instrument. A cooperative agreement differs from a standard research grant in that it typically involves substantial scientific or programmatic involvement from the NIH during the project. While the exact oversight expectations would be defined in the full FOA text, applicants generally should expect closer coordination with NIH staff than under a traditional investigator-initiated grant, especially given that the trials are being supported as part of a targeted NIH programmatic effort.

The opportunity falls under the broad activity area of health, specifically listed with the CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), aligning it with NIH efforts in diabetes and related conditions. The announcement indicates there is no cost-sharing or matching requirement, so applicants are not required to commit non-federal matching funds as a condition of the award. The estimated total funding level for the program is listed as $26,000,000, suggesting NIH anticipated supporting multiple clinical trials or substantial trial budgets under this initiative.

Eligibility is broad in terms of institutional types, but narrow in terms of who can actually apply due to the limited-competition requirement tied to the prior R34 awards. The eligible applicant categories include a wide range of U.S.-based organizations such as for-profit entities (including small businesses), nonprofit organizations (including 501(c)(3) and non-501(c)(3) nonprofits), public and private institutions of higher education, state and local governments, tribal governments and tribal organizations, public housing authorities, school districts, and special district governments. The eligibility section also explicitly mentions various institution types such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and AANAPISIs, as well as faith-based or community-based organizations and eligible federal agencies. At the same time, the FOA makes clear that non-U.S. entities (foreign institutions) and non-U.S. components of U.S. organizations are not eligible to apply, although foreign components as defined by the NIH Grants Policy Statement are allowed, which typically means certain parts of the research may involve foreign collaboration or activities under NIH rules without the applicant institution itself being foreign.

Key dates show the FOA was posted on December 14, 2012, with an original closing date of March 15, 2013, later updated to a current closing date of April 3, 2013. The archive date is May 3, 2013, indicating it is no longer an active solicitation and is provided for historical reference. The listing includes an additional information link to the NIH guide page for the full announcement, and provides NIH Office of Extramural Research (OER) webmaster contact emails for technical access or linking issues related to the online posting.

Overall, this UC4 announcement is best understood as a targeted NIH bridge from planning to execution: investigators who previously secured R34 planning support under a specific diabetes clinical trial planning initiative were invited, through this limited competition, to request cooperative agreement funding to run the full clinical trials they had already proposed, with the ultimate goal of improving blood glucose management and/or reducing the burden of complications in Type 1 diabetes.

Browse more business programs for Diabetes Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome wide Data (R03)

Previous opportunity: U.S. Embassy Islamabad PAS Grants Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 12 511

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 12 511) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 12 511", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.